147 related articles for article (PubMed ID: 34548912)
1. Targeting AP-1 transcription factors by CRISPR in the prostate.
Riedel M; Cai H; Stoltze IC; Vendelbo MH; Wagner EF; Bakiri L; Thomsen MK
Oncotarget; 2021 Sep; 12(19):1956-1961. PubMed ID: 34548912
[TBL] [Abstract][Full Text] [Related]
2. In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun.
Riedel M; Berthelsen MF; Cai H; Haldrup J; Borre M; Paludan SR; Hager H; Vendelbo MH; Wagner EF; Bakiri L; Thomsen MK
Oncogene; 2021 Apr; 40(13):2437-2447. PubMed ID: 33674748
[TBL] [Abstract][Full Text] [Related]
3. Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters.
Langer S; Singer CF; Hudelist G; Dampier B; Kaserer K; Vinatzer U; Pehamberger H; Zielinski C; Kubista E; Schreibner M
Eur J Gynaecol Oncol; 2006; 27(4):345-52. PubMed ID: 17009623
[TBL] [Abstract][Full Text] [Related]
4. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
Cook SJ; Aziz N; McMahon M
Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
[TBL] [Abstract][Full Text] [Related]
5. Two proximal activating protein-1-binding sites are sufficient to stimulate transcription of the ovine follicle-stimulating hormone-beta gene.
Strahl BD; Huang HJ; Pedersen NR; Wu JC; Ghosh BR; Miller WL
Endocrinology; 1997 Jun; 138(6):2621-31. PubMed ID: 9165057
[TBL] [Abstract][Full Text] [Related]
6. JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells.
Rao GN; Katki KA; Madamanchi NR; Wu Y; Birrer MJ
J Biol Chem; 1999 Feb; 274(9):6003-10. PubMed ID: 10026227
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of c-jun, junB, AP-1, and preproenkephalin mRNA in rat striatum following a single injection of caffeine.
Svenningsson P; Ström A; Johansson B; Fredholm BB
J Neurosci; 1995 May; 15(5 Pt 1):3583-93. PubMed ID: 7751931
[TBL] [Abstract][Full Text] [Related]
8. Induction of c-fos, c-jun, junB and junD mRNA and AP-1 by alkylating mutagens in cells deficient and proficient for the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) and its relationship to cell death, mutation induction and chromosomal instability.
Dosch J; Kaina B
Oncogene; 1996 Nov; 13(9):1927-35. PubMed ID: 8934539
[TBL] [Abstract][Full Text] [Related]
9. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.
McCabe LR; Banerjee C; Kundu R; Harrison RJ; Dobner PR; Stein JL; Lian JB; Stein GS
Endocrinology; 1996 Oct; 137(10):4398-408. PubMed ID: 8828501
[TBL] [Abstract][Full Text] [Related]
10. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
11. Activation and inhibition of the AP-1 complex in human breast cancer cells.
Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
[TBL] [Abstract][Full Text] [Related]
12. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
13. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors.
Zenz R; Wagner EF
Int J Biochem Cell Biol; 2006; 38(7):1043-9. PubMed ID: 16423552
[TBL] [Abstract][Full Text] [Related]
14. Electrostatic repulsion causes anticooperative DNA binding between tumor suppressor ETS transcription factors and JUN-FOS at composite DNA sites.
Madison BJ; Clark KA; Bhachech N; Hollenhorst PC; Graves BJ; Currie SL
J Biol Chem; 2018 Nov; 293(48):18624-18635. PubMed ID: 30315111
[TBL] [Abstract][Full Text] [Related]
15. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration.
Hsu JC; Bravo R; Taub R
Mol Cell Biol; 1992 Oct; 12(10):4654-65. PubMed ID: 1406655
[TBL] [Abstract][Full Text] [Related]
16. Activation of mu-opioid receptor induces expression of c-fos and junB via mitogen-activated protein kinase cascade.
Shoda T; Fukuda K; Uga H; Mima H; Morikawa H
Anesthesiology; 2001 Oct; 95(4):983-9. PubMed ID: 11605942
[TBL] [Abstract][Full Text] [Related]
17. MG-132 sensitizes TRAIL-resistant prostate cancer cells by activating c-Fos/c-Jun heterodimers and repressing c-FLIP(L).
Li W; Zhang X; Olumi AF
Cancer Res; 2007 Mar; 67(5):2247-55. PubMed ID: 17332355
[TBL] [Abstract][Full Text] [Related]
18. Neuronal regulation of c-fos, c-jun, and junB immediate-early genes in rat adrenal medulla.
Pelto-Huikko M; Dagerlind A; Kononen J; Lundberg JM; Villar M; Koistinaho J; Bravo R; Hökfelt T
J Neurosci; 1995 Mar; 15(3 Pt 1):1854-68. PubMed ID: 7891139
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation in the testis: a role for transcription factor AP-1 complexes at various stages of spermatogenesis.
Cohen DR; Vandermark SE; McGovern JD; Bradley MP
Oncogene; 1993 Feb; 8(2):443-55. PubMed ID: 8426749
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of conventional and real-time RT-PCR for the quantitation of jun protooncogene mRNA and analysis of junB mRNA expression in synovial membranes and isolated synovial fibroblasts from rheumatoid arthritis patients].
Huber R; Kunisch E; Glück B; Egerer R; Sickinger S; Kinne RW
Z Rheumatol; 2003 Aug; 62(4):378-89. PubMed ID: 12928942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
